Antiphospholipid Syndrome

Top Story

Pregnant patients with antiphospholipid syndrome may benefit from addition of aspirin to treatment

July 6, 2017

MADRID — Pregnant patients with antiphospholipid syndrome managed with conventional treatments appear to have a high level of obstetrical complications and may benefit from the addition of aspirin to their regimen, according to a study presented at the EULAR Annual Congress.

“We report a high level of obstetrical complication in these patients, despite treatment,” presenter Cecile M. Yelnik, MD, said. “We also found a beneficial effect of adding aspirin to prevent obstetric morbidity. Heparin and aspirin were well tolerated and did not increase risk of hemorrhage. A therapeutic trial is needed to confirm the safety profile.”

Meeting News

Triple-therapy regimen associated with improved survival in catastrophic antiphospholipid syndrome

June 16, 2017
MADRID — A triple regimen of anticoagulation therapy, corticosteroids and plasma exchange and/or immunoglobulins was associated with reduced mortality among…
In the JournalsPerspective

EULAR publishes recommendations for women with lupus

March 9, 2017
A team of EULAR researchers published recommendations for health issues and family planning for women with lupus or antiphospholipid syndrome. Laura Andreoli
Meeting News Coverage

Lupus anticoagulant associated with risks in patients with aPL antibodies

December 15, 2015
Most events related to antiphospholipid-positivity were not associated with the antiphospholipid antibody profile, however, an association was observed between the risk…
More Headlines »